IU Simon Cancer Center

International Impact of Physician Scientists

Throughout its history, IU Simon Cancer Center researchers have made seminal discoveries and other contributions that have influenced the treatment of myriad cancers in the United States and around the world. Through their leadership, IU Simon Cancer Center physician-scientists bring recognition to Indiana as a significant contributor to the life sciences field and biomedical research.

Hal Broxmeyer, PhD

Hal Broxmeyer, PhD

Distinguished Professor
Hal Broxmeyer, PhD, was instrumental in the first umbilical cord stem cell transplant conducted in the world that allows curative treatment with substantially less toxicity than conventional bone marrow transplantation.
D. Clapp, MD

D. Clapp, MD

Chair, Department of Pediatrics
D. Wade Clapp, MD, was at the forefront of identifying effective treatments for NF1, a previously untreatable and sometimes life-threatening class of tumors.
Lawrence Einhorn, MD

Lawrence Einhorn, MD

Distinguished Professor
Lawrence Einhorn, MD, developed the curative chemotherapy regimen for testis cancer, the most common cancer seen in young men. His clinical research team was instrumental in the approval of cisplatin, etoposide and ifosfamide by the FDA.
Theresa Guise, MD

Theresa Guise, MD

Jerry W. and Peggy S. Throgmartin Professor of Oncology
Theresa Guise, MD, is among only a few researchers in the US who evaluate the mechanisms of commonly seen side effects in patients with cancer, including cognitive dysfunction (or “chemo brain”) and cachexia (loss of body weight and muscle mass).
Teresa Zimmers, PhD

Teresa Zimmers, PhD

Professor of Surgery
Teresa Zimmers, PhD, is among only a few researchers in the country who evaluate the mechanisms of commonly seen side effects in patients with cancer, including cognitive dysfunction (or “chemo brain”) and cachexia (loss of body weight and muscle mass).
Patrick Loehrer, MD

Patrick Loehrer, MD

Distinguished Professor
Patrick Loehrer, MD, led a team that established the standard of care for thymic cancers worldwide and was the clinical co-leader of a research team that explained the molecular aspects of developing this rare cancer for The Cancer Genome Atlas. He led creation of the AMPATH Oncology program in western Kenya.
Anna Storniolo, MD

Anna Storniolo, MD

Andrew and Peggy Thomson Professor of Hematology Oncology
Anna Maria Storniolo, MD, and colleagues established the Susan G. Komen Tissue Bank at IU Simon Cancer Center, the world’s only healthy breast tissue bank.